An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins—including ...

Gene‑edited HPSCs programmed to make therapeutic antibodies and proteins show long‑lasting, boostable immunity in mouse models.

Ferns, defined by large genomes, high chromosome counts, and pervasive aneuploidy as well as intraspecific polyploid complexity, diverge significantly from the classical genetic theories and ...